Day One Biopharmaceuticals (DAWN) Earnings Date & Reports
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
DAWN is expected to report earnings to fall 35.22% to -40 cents per share on May 07
Q1'25
Est.
$-0.41
Q4'24
Missed
by $0.17
Q3'24
Beat
by $0.70
Q2'24
Beat
by $0.70
Q1'24
Missed
by $0.07
The last earnings report on February 25 showed earnings per share of -62 cents, missing the estimate of -46 cents. With 396.23K shares outstanding, the current market capitalization sits at 807.80M.